文献速递糖尿病骨质疏松与钙磷/甲状旁腺

2型糖尿病对股骨头小梁骨质量的多尺度影响研究

Investigation of Mechanical, Material, and Compositional Determinants of Human Trabecular Bone Quality in Type 2 Diabetes.
PubMed 文献 · J Clin Endocrinol Metab · 2021-01-01

本研究比较了因脆性髋部骨折行置换术的非糖尿病(n=40)与糖尿病(n=30,平均病程7.5±2.8年)患者股骨头小梁骨样本,发现两组面积骨密度(aBMD)无显著差异,但糖尿病组骨体积分数更低、表观韧性和屈服后能量更低,组织水平模量和硬度更低,且矿物:基质比更低、矿物晶体更宽、骨胶原晚期糖基化终末产物(fAGEs)和非酶交联比(NE-xLR)更高。NE-xLR与屈服后应变、fAGEs与屈服后能量及韧性呈强负相关,提示高血糖在多尺度上损害小梁骨质量。

要点

  • 2型糖尿病患者的aBMD与非糖尿病者无显著差异,但小梁骨微结构更差(骨体积分数更低)。
  • 糖尿病组骨组织材料性能下降:表观韧性、屈服后能量、组织模量和硬度均更低。
  • 骨胶原非酶交联(NE-xLR)和fAGEs升高与骨韧性及能量吸收下降强负相关。

核心结论

  • 2型糖尿病在首次髋部脆性骨折后的小梁骨中表现出多尺度的质量损害,导致能量吸收和韧性降低,提示骨脆性增加。

研究设计与样本

  • 收集因脆性髋部骨折行置换术患者的股骨头骨组织标本,比较非糖尿病组(n=40)与糖尿病组(n=30,平均病程7.5±2.8年)的小梁骨质量参数。

主要发现

  • 两组间aBMD无显著差异。
  • 糖尿病组骨体积分数(BV/TV)更低,归因于骨小梁数量更少且更薄。
  • 糖尿病组表观韧性和屈服后能量更低。
  • 糖尿病组组织水平(纳米压痕)模量和硬度更低。
  • 糖尿病组矿物:基质比更低、矿物晶体更宽,骨胶原fAGEs更高、NE-xLR更高、二级结构(酰胺带)改变。

临床怎么用

  • 对于2型糖尿病患者,即使aBMD正常,也应关注骨脆性风险,因其骨材料性能和微结构可能已受损。
  • 骨胶原交联指标(如fAGEs、NE-xLR)可能有助于解释糖尿病相关骨脆性,但尚需进一步验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

CONTEXT: Increased bone fragility and reduced energy absorption to fracture associated with type 2 diabetes (T2D) cannot be explained by bone mineral density alone. This study, for the first time, reports on alterations in bone tissue's material properties obtained from individuals with diabetes and known fragility fracture status. OBJECTIVE: To investigate the role of T2D in altering biomechanical, microstructural, and compositional properties of bone in individuals with fragility fracture. METHODS: Femoral head bone tissue specimens were collected from patients who underwent replacement surgery for fragility hip fracture. Trabecular bone quality parameters were compared in samples of 2 groups, nondiabetic (n = 40) and diabetic (n = 30), with a mean duration of disease 7.5 ± 2.8 years. RESULTS: No significant difference was observed in aBMD between the groups. Bone volume fraction (BV/TV) was lower in the diabetic group due to fewer and thinner trabeculae. The apparent-level toughness and postyield energy were lower in those with diabetes. Tissue-level (nanoindentation) modulus and hardness were lower in this group. Compositional differences in the diabetic group included lower mineral:matrix, wider mineral crystals, and bone collagen modifications-higher total fluorescent advanced glycation end-products (fAGEs), higher nonenzymatic cross-link ratio (NE-xLR), and altered secondary structure (amide bands). There was a strong inverse correlation between NE-xLR and postyield strain, fAGEs and postyield energy, and fAGEs and toughness. CONCLUSION: The current study is novel in examining bone tissue in T2D following first hip fragility fracture. Our findings provide evidence of hyperglycemia's detrimental effects on trabecular bone quality at multiple scales leading to lower energy absorption and toughness indicative of increased propensity to bone fragility.

来源:J Clin Endocrinol Metab,查看原文。版权归原作者所有。

引用

  1. Sihota P, Yadav RN, Dhaliwal R, et al. Investigation of Mechanical, Material, and Compositional Determinants of Human Trabecular Bone Quality in Type 2 Diabetes. J Clin Endocrinol Metab. 2021. PMID: 33475711. doi:10.1210/clinem/dgab027

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。